, a bio/informatics shared resource is still "open for business" - Visit the CDS website


  1. A three-dimensional computational model of collagen network mechanics. Lee B, Zhou X, Riching K, Eliceiri KW, Keely PJ, Guelcher SA, Weaver AM, Jiang Y (2014) PLoS One 9(11): e111896
    › Primary publication · 25386649 (PubMed) · PMC4227658 (PubMed Central)
  2. 3D collagen alignment limits protrusions to enhance breast cancer cell persistence. Riching KM, Cox BL, Salick MR, Pehlke C, Riching AS, Ponik SM, Bass BR, Crone WC, Jiang Y, Weaver AM, Eliceiri KW, Keely PJ (2014) Biophys J 107(11): 2546-58
    › Primary publication · 25468334 (PubMed) · PMC4255204 (PubMed Central)
  3. What lies beneath: looking beyond tumor genetics shows the complexity of signaling networks underlying drug sensitivity. Quaranta V, Tyson DR (2013) Sci Signal 6(294): pe32
    › Primary publication · 24065144 (PubMed)
  4. WAVE2 regulates epithelial morphology and cadherin isoform switching through regulation of Twist and Abl. Bryce NS, Reynolds AB, Koleske AJ, Weaver AM (2013) PLoS One 8(5): e64533
    › Primary publication · 23691243 (PubMed) · PMC3654908 (PubMed Central)
  5. Synthetic and tissue-derived models for studying rigidity effects on invadopodia activity. Weaver AM, Page JM, Guelcher SA, Parekh A (2013) Methods Mol Biol : 171-89
    › Primary publication · 23868588 (PubMed)
  6. Signaling inputs to invadopodia and podosomes. Hoshino D, Branch KM, Weaver AM (2013) J Cell Sci 126(Pt 14): 2979-89
    › Primary publication · 23843616 (PubMed) · PMC3711196 (PubMed Central)
  7. Programming biological models in Python using PySB. Lopez CF, Muhlich JL, Bachman JA, Sorger PK (2013) Mol Syst Biol : 646
    › Primary publication · 23423320 (PubMed) · PMC3588907 (PubMed Central)
  8. Exosome secretion is enhanced by invadopodia and drives invasive behavior. Hoshino D, Kirkbride KC, Costello K, Clark ES, Sinha S, Grega-Larson N, Tyska MJ, Weaver AM (2013) Cell Rep 5(5): 1159-68
    › Primary publication · 24290760 (PubMed) · PMC3873329 (PubMed Central)
  9. Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer. Udyavar AR, Hoeksema MD, Clark JE, Zou Y, Tang Z, Li Z, Li M, Chen H, Statnikov A, Shyr Y, Liebler DC, Field J, Eisenberg R, Estrada L, Massion PP, Quaranta V (2013) BMC Syst Biol : S1
    › Primary publication · 24564859 (PubMed) · PMC4029366 (PubMed Central)
  10. Clinically relevant modeling of tumor growth and treatment response. Yankeelov TE, Atuegwu N, Hormuth D, Weis JA, Barnes SL, Miga MI, Rericha EC, Quaranta V (2013) Sci Transl Med 5(187): 187ps9
    › Primary publication · 23720579 (PubMed) · PMC3938952 (PubMed Central)